We are live on ! Find out more
KXA

KPCB XV Associates Portfolio holdings

AUM $35.8M
1-Year Est. Return 57.59%
This Fund
S&P 500
This Quarter Est. Return
+90.97%
1 Year Est. Return
-57.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$232M
AUM Growth
-$655K
Cap. Flow
-$69.9M
Cap. Flow %
-30.12%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TWLO icon
Twilio
TWLO
+$69.9M

Sector Composition

Rank Sector Weight
1 Financials 42.36%
2 Healthcare 30.23%
3 Technology 27.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPST icon
1
Upstart Holdings
UPST
$2.74B
$98.3M 42.36%
847,788
TWLO icon
2
Twilio
TWLO
$27.8B
$63.6M 27.41%
186,667
-186,666
-50% -$69.9M
RAPT
3
DELISTED
RAPT Therapeutics
RAPT
$43.2M 18.62%
243,383
ATRA icon
4
Atara Biotherapeutics
ATRA
$73.3M
$26.9M 11.61%
75,066

Similar funds

KPCB XV Associates's Q1 2021 Portfolio in Review

As of Q1 2021, KPCB XV Associates held 4 positions worth $232M, down 0.28% from $233M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XV Associates withdrew a net $69.9M in Q1 2021, reducing 1 holding. Its largest reduction was Twilio, cutting an estimated $69.9M.

By sector, the portfolio is most concentrated in Financials at 42% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

  • KPCB XV Associates's biggest Q1 2021 reduction was Twilio, cutting an estimated $69.9M.
  • KPCB XV Associates's ten largest holdings make up 100% of its $232M portfolio in Q1 2021.
  • KPCB XV Associates opened 0 new positions and closed 0 in Q1 2021.
  • KPCB XV Associates's portfolio value fell 0.28% quarter-over-quarter to $232M.

Based on KPCB XV Associates's 13F filing for Q1 2021, filed 13 May 2021.